Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fritzsche

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Histology and Histopathology|July 18, 2009
Prognostic significance of AGR2 in pancreatic ductal adenocarcinomaMarc-Oliver Riener, Christian Pilarsky, Josefine Gerhardt, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Radiosynthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)Barbara Wenzel, Stefan R Fritzsche, Magali Toussaint, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2006
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosisFlorian R Fritzsche, Monika Jung, Chuanliang Xu, et al.
Histopathology|June 16, 2010
Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue markerVerena Tischler, Florian R Fritzsche, Josefine Gerhardt, et al.
Human Pathology|May 27, 2009
IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomasMarc-Oliver Riener, Florian R Fritzsche, Pierre-Alain Clavien, et al.
Chempluschem|March 3, 2021
Hybrid Peptides Based on α-Aminoxy Acids as Antimicrobial and Anticancer FoldamersLaura Sinatra, Lisa Kolano, Maik Icker, et al.
Histology and Histopathology|July 25, 2007
Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancerF R Fritzsche, A Thomas, K-J Winzer, et al.
International Journal of Cancer|May 18, 2010
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomyAnja Rabien, Florian R Fritzsche, Monika Jung, et al.
Histology and Histopathology|October 6, 2011
Expression of histone deacetylases 1, 2 and 3 in histological subtypes of testicular germ cell tumoursFlorian R Fritzsche, Anja Hasler, Peter K Bode, et al.
BMC Cancer|June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progressionFlorian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Histology and Histopathology|July 18, 2009
Prognostic significance of AGR2 in pancreatic ductal adenocarcinomaMarc-Oliver Riener, Christian Pilarsky, Josefine Gerhardt, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
Radiosynthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)Barbara Wenzel, Stefan R Fritzsche, Magali Toussaint, et al.
Virchows Archiv : an International Journal of Pathology|November 16, 2006
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosisFlorian R Fritzsche, Monika Jung, Chuanliang Xu, et al.
Histopathology|June 16, 2010
Comparison of the diagnostic value of fatty acid synthase (FASN) with alpha-methylacyl-CoA racemase (AMACR) as prostatic cancer tissue markerVerena Tischler, Florian R Fritzsche, Josefine Gerhardt, et al.
Human Pathology|May 27, 2009
IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomasMarc-Oliver Riener, Florian R Fritzsche, Pierre-Alain Clavien, et al.
Chempluschem|March 3, 2021
Hybrid Peptides Based on α-Aminoxy Acids as Antimicrobial and Anticancer FoldamersLaura Sinatra, Lisa Kolano, Maik Icker, et al.
Histology and Histopathology|July 25, 2007
Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancerF R Fritzsche, A Thomas, K-J Winzer, et al.
International Journal of Cancer|May 18, 2010
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomyAnja Rabien, Florian R Fritzsche, Monika Jung, et al.
Histology and Histopathology|October 6, 2011
Expression of histone deacetylases 1, 2 and 3 in histological subtypes of testicular germ cell tumoursFlorian R Fritzsche, Anja Hasler, Peter K Bode, et al.
BMC Cancer|June 28, 2008
ADAM9 is highly expressed in renal cell cancer and is associated with tumour progressionFlorian R Fritzsche, Kirsten Wassermann, Monika Jung, et al.
Pageof 6